MedicaidCoverageMedium impact
BT2022116: IHCP removing coverage of COVID-19 treatment codes for bebtelovimab
Indiana Medicaid (IHCP)·IN · Emergency Medicine, Critical Care, Infectious Disease +2 more·Medical Policy
Effective date
Nov 30, 2022
We identified it
Jun 19, 2026
Summary
IHCP (Indiana Medicaid) has removed coverage for bebtelovimab COVID-19 treatment codes effective November 30, 2022, following FDA withdrawal of Emergency Use Authorization. Three specific HCPCS codes (M0222, M0223, Q0222) are no longer covered and affected claims will be reprocessed.
Action Required
Immediately: Stop billing codes M0222, M0223, and Q0222 for bebtelovimab COVID-19 treatment for Indiana Medicaid patients with dates of service on or after November 30, 2022. Billing team must update system to flag these codes as non-covered for IHCP. Review any pending claims with these codes as they will be denied and reprocessed.